← All trials
NCT03856827
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 17, 2019
- Primary completion
- Sep 16, 2019
- Completion date
- Sep 16, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 136
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cyclerion Therapeutics, Inc.Lead sponsor
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.